Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
Updated on: September 10, 2015
continues to work with Congress, federal agencies, and other stakeholders to
ensure continued access to safe and effective hematologic drugs.
FDA Reports Supply Issue with Cytarabine InjectionOn March 13, the FDA informed ASH of a potential supply
issue for cytarabine injection. The FDA
has not posted the shortage to their website because they are working closely
with the drug manufacturers to try and prevent supply impact. The American Society of Health-System
Pharmacists has posted details about the shortage on their website, which is
linked in the list below. If you have
any questions or concerns, please contact ASH or the FDA’s drug shortage office.
Blood: How I Treat Hematology 2014 ASH Academy ASH On Demand
December 5-8, 2015 Orlando, FL
Register now to attend the premier event in malignant & non-malignant hematology.
ASH Annual Meeting December 5, 2015, 2:00 p.m.
Explore the opportunities and controversies of quality measurement in medical care during this symposium
ASH Annual Meeting December 6, 2015, 11:15 a.m.
During this program, learn about new payment models that are under development for hematologic conditions as part of the Affordable Care Act.
ASH Annual Meeting December 7, 2015, 12:15 p.m.
Attend this session to learn about the top five Choosing Wisely recommendations from other societies of relevance and importance to the practice of hematology.
ASH Annual Meeting December 7, 2015, 4:30 p.m.
Get the latest information from FDA product reviewers on safety and efficacy issues from the clinical trials and toxicity studies for recently approved drugs.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology